First Solar, Inc. vs Medtronic PLC — how do they compare? First Solar, Inc. trades at $212.07 (market cap $24.05B), while Medtronic PLC trades at $83.31 (market cap $103.01B). The key difference: Medtronic PLC is far larger — about 4.3× First Solar, Inc.'s market cap, and Medtronic PLC pays a 3.58% dividend while First Solar, Inc. pays none. Which is the better fit depends on your goals.
| FSLR | MDT | |
|---|---|---|
Market Cap | $24.05B | $103.01B |
Sector | Technology | Health |
52-Week High | $318.30 | $105.35 |
52-Week Low | $166.82 | $73.75 |
Enterprise Value | $22.21B | $121.75B |
Dividend Yield | — | 3.58% |
Signals from Pluang's Aura AI — not financial advice
First Solar (FSLR) trades at $213.15, down 3.37% amid bearish technical signals and class action lawsuit headlines. The stock shows strong fundamentals with a P/E of 14.46, net income margin of 30.73%, and robust cash flow growth, though recent earnings misses and legal overhangs weigh on sentiment. Revenue climbed to $5.22B in 2025, with projected growth to $5.4B in 2026, supported by expanding operating cash flows.
The outlook balances solid profitability and analyst bullishness (60% buy ratings, $275.17 target) against near-term legal risks and technical weakness. Upside hinges on lawsuit resolution and execution of growth forecasts, while downside risks include prolonged litigation and competitive pressures in solar tech.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →